Table 1.

Patients demographics and clinical data according to treatment Group

Group	I: Chemotherapy (#17)	II: Hormone therapy (#15)	III: NSAIDS (#16)	IV: Radiotherapy (#13)	V: Surgery (#257)	VI: Active surveillance (#70)	Overall (#388)
Age (years)
Mean	30,8	39,7	38,1	45,8	36,6	40,6	37,5
Min	10	15	11	15	3	10	3
Max	53	74	63	69	81	85	85
Gender
Female	10	11	8	7	158	46	240
Male	7	4	8	6	99	24	148
Presentation
Primary	11	10	14	11	193	57	296
Recurrent	6	5	2	2	62	13	90
Diagnosis delay
Mean	20,9	15,8	15,2	13,5	13,1	13,5	13,8
Min	1	1	2	1	0	0	0
Max	72	72	53	60	120	120	120
Biopsy
Incisional	15	10	3	1	134	27	190
Needle	2	5	13	11	98	41	170
Beta catenin
Not invastigated	13	9	5	2	179	39	247
Negative			1		7	3	11
Positive	4	6	10	10	57	25	112
Location
Arm		2	1		25	9	37
Foot	1				8	2	11
Forearm	2				12	4	18
Hand/wrist					3		3
Leg	2	2	2	3	23	3	35
Pelvic girdle	5	5	4		41	17	72
Shoulder girdle	3	5	7	7	78	19	119
Thigh	4		1	3	53	12	73
Size
< 5 cm	3	3	5		78	24	113
5–10 cm	7	9	5	9	118	32	180
> 10 cm	7	3	6	4	56	13	89
Location
Deep	17	15	15	12	208	57	324
Extra-fascial			1	1	38	11	51
Nerve Involvement
Present	4	3	3	8	40	9	67
Neurologic symptoms
Present	3	4	2	4	28	4	45
Previous local events
Surgery	6	5	1	1	38	17	68
Trauma	2	1	3	1	22	4	33
Hormonal status (females only)
Menopause	1		3		22	7	33
Pregnancy	1				2	1	4
Recent pregnancy	1			1	5	4	11
Pain
Absent	3	3	4	3	97	25	135
Mild	9	4	5	7	74	34	133
Moderate	4	7	6		45	9	71
Severe	1	1	1	3	11	1	18